Alterity Therapeutics Limited (ATHE)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
As of 11:28AM EDT. Market open.
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 16.79M |
| Enterprise Value | 6.81M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 737.73 |
| Price/Book (mrq) | 1.19 |
| Enterprise Value/Revenue | -1.18k |
| Enterprise Value/EBITDA | -0.48 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 0.76 |
| 52-Week Change 3 | -29.47% |
| S&P500 52-Week Change 3 | 21.61% |
| 52 Week High 3 | 5.4100 |
| 52 Week Low 3 | 1.5500 |
| 50-Day Moving Average 3 | 1.9222 |
| 200-Day Moving Average 3 | 2.3738 |
Share Statistics
| Avg Vol (3 month) 3 | 80.74k |
| Avg Vol (10 day) 3 | 301.88k |
| Shares Outstanding 5 | 8.73M |
| Implied Shares Outstanding 6 | 4.46M |
| Float 8 | 2.54B |
| % Held by Insiders 1 | 0.00% |
| % Held by Institutions 1 | 1.00% |
| Shares Short (Mar 28, 2024) 4 | 23.05k |
| Short Ratio (Mar 28, 2024) 4 | 0.77 |
| Short % of Float (Mar 28, 2024) 4 | N/A |
| Short % of Shares Outstanding (Mar 28, 2024) 4 | 0.26% |
| Shares Short (prior month Feb 29, 2024) 4 | 17.92k |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | 1:10 |
| Last Split Date 3 | Jan 09, 2023 |
Financial Highlights
Currency in AUD.Fiscal Year
| Fiscal Year Ends | Jun 30, 2023 |
| Most Recent Quarter (mrq) | Dec 31, 2023 |
Profitability
| Profit Margin | 0.00% |
| Operating Margin (ttm) | -348.40% |
Management Effectiveness
| Return on Assets (ttm) | -28.94% |
| Return on Equity (ttm) | -53.72% |
Income Statement
| Revenue (ttm) | 3.43M |
| Revenue Per Share (ttm) | 0.60 |
| Quarterly Revenue Growth (yoy) | -20.30% |
| Gross Profit (ttm) | N/A |
| EBITDA | -12.83M |
| Net Income Avi to Common (ttm) | -12.28M |
| Diluted EPS (ttm) | -1.8700 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 12.32M |
| Total Cash Per Share (mrq) | 0 |
| Total Debt (mrq) | 255.6k |
| Total Debt/Equity (mrq) | 1.45% |
| Current Ratio (mrq) | 4.89 |
| Book Value Per Share (mrq) | 0.01 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -14.61M |
| Levered Free Cash Flow (ttm) | -9.95M |
© 2024 Yahoo. All rights reserved.